PRKN and amyotrophic lateral sclerosis: To date, Palomo et al. (2018) have reported decreased parkin protein with unchanged mRNA levels in a genetic ALS model (mice with G93A SOD1 pathogenic variant) characterized by TDP-43 proteinopathy.